Studies of osteotropism on both sides of the breast cancer-bone interaction

Annals of the New York Academy of Sciences

Volumn 1117, Issue , 2007, Pages 328-344

  Moreau, Jodie ^a   Anderson, Kristen M ^a   Mauney, Joshua R ^b   Kaplan, David ^b   Rosenblatt, Michael ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tufts University   (United States)

Author keywords

Animal model; Bone stroma; Breast cancer; Metastasis; Osteotropism; Skeletal metastasis; Tumor stroma

Indexed keywords

BRCA1 PROTEIN; TRANSCRIPTOME;

BONE GRAFT; BONE METASTASIS; BONE TRANSPLANTATION; BREAST CANCER; CANCER CELL; CANCER MODEL; CELL SELECTION; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NONHUMAN; NONOBESE DIABETIC MOUSE; SCID MOUSE; STROMA; TISSUE ENGINEERING;

ANIMALIA; MUS;

EID: 36549016147     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.003     Document Type: Conference Paper

References (71)

1. JEMAL, A., T. MURRAY, E. WARD, et al. 2005. Cancer statistics, 2005. CA Cancer J. Clin. 55: 10-30.
2. COLEMAN, R.E. 2002. Future directions in the treatment and prevention of bone metastases. Am. J. Clin. Oncol. 25: S32-S38.
3. MUNDY, G.R. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2: 584-593.
4. DEIL, I.J., E.F. SOLOMAYER & G. BASTERT. 2000. Treatment of metastatic bone disease in breast cancer, bisphosphonates. Clin. Breast Cancer 1: 43-51.
5. ROODMAN, G.D. 2004. Mechanisms of bone metastasis. N. Engl. J. Med. 350: 1655-1664.
6. RUBENS, R.D. & I. FOGELMAN. 1991. The nature of metastatic bone disease. In Bone Metastases: Diagnosis and Treatment. R.D. Rubens & I. Fogelman, Eds.: 1-10. Springer. London.
7. ASLAKSON, C.J. & F.R. MILLER. 1992. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52: 1399-1405.
8. CHAMBERS, A.F., A.C. GROOM & J.C. MACDONALD. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2: 563-572.
9. FIDLER, I.J. 2003. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3: 453-458.
10. YONEDA, T. 2000. Cellular and molecular basis of preferential metastasis of breast cancer to bone. J. Orthop. Sci. 5: 75-81.
11. RODAN, G. 2003. The development and function of the skeleton and bone metastases. Cancer 97: 726-732.
12. YONEDA, T. & T. HIRAGA. 2005. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem. Biophys. Res. Commun. 328: 679-687.
13. WEBER, M.H., D. GOLTZMAN, P. KOSTENUIK, et al. 2000. Mechanism of tumor metastasis to bone. Crit. Rev. Eukaryotic Gene Express. 10: 281-302.
14. GOLTZMAN, D. 2001. Osteolysis and cancer. J. Clin. Invest. 107: 1219-1220.
15. BAUERLE, T., H. ADWAN, F. KIESSLING, et al. 2005. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int. J. Cancer 115: 177-186.
16. SLOAN, E.K. & R.L. ANDERSON. 2002. Genes involved in breast cancer metastasis to bone. Cell Mol. Life Sci. 59: 1491-1502.
17. NOTI, J.D. 2000. Adherence to osteopontin via alpha v beta 3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha. Int. J. Oncol. 17: 1237-1243.
18. WALTREGNY, D., A. BELLAHCENE, X. DE LEVAL, et al. 2000. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J. Bone Miner. Res. 15: 834-843.
19. IBRAHIM, T., I. LEONG, O. SANCHEZ- SWEATMAN, et al. 2000. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin. Exp. Metastasis 18: 253-260.
20. RAJOTTE, D., W. ARAP, M. HAGEDORN, et al. 1998. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102: 430-437.
21. ARAP, W., M.G. KOLONIN, M. TREPEL, et al. 2002. Steps toward mapping the human vasculature by phage display. Nat. Med. 8: 121-127.
22. ABRAMOVITCH, R., H. DAFNI, M. NEEMAN, et al. 1999. Inhibition of neovascularizaton and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis. Neoplasia 1: 321-329.
23. AL-MEHDI, A.B., K. TOZAWA, A.B. FISHER, et al. 2000. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6: 100-102.
24. BELLAHCENE, A. & V. CASTRONOVO. 1997. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bulletin du Cancer 84: 17-24.
25. FATA, J., Y. KONG, L. JI, et al. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41-50.
26. JAVED, A., G. BARNES, J. PRATAP, et al. 2005. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. PNAS 102: 1454-1459.
27. BARNES, G., K. HEBERT, M. KAMAL, et al. 2004. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Res. 64: 4506-4513.
28. SHORE, P. 2006. A role for Runx2 in normal mammary gland and breast cancer bone metastasis. J. Biol. Chem. 96: 484-489.
29. HUNT, N.C. A., Y. FUJIKAWA, A. SAKOBHAR, et al. 2001. Cellular mechanism of bone resorption in breast carcinoma. Br. J. Cancer 85: 78-84.
30. BOYDE, A., E. MACONNACHIE, S.A. REID, et al. 1986. Scanning electron microscopy in bone pathology; review of methods, potential and applications. Scan Electron. Microsc. 4: 1537-1554.
31. CHIRGWIN, J.M. & T.A. GUISE. 2001. Molecular mechanism of tumor-bone interactions in osteolytic metastases. Crit. Rev. Eukaryotic Gene Expr. 10: 159-178.
32. LINDEMANN, R.K., P. BALLSCHMIETER, A. NORDHEIM, et al. 2001. Transforming growth factor regulates parathyroid hormone-related protein expression in MDAMB-231 breast cancer cells through a novel smad/ets synergism. J. Biol. Chem. 276: 46661-46670.
33. GUISE, T.A. 2000. Molecular mechanism of osteolytic bone metastases. Cancer 88: 2892-2898.
34. BOYCE, B.F., T. YONEDA & T.A. GUISE. 1999. Factors regulating the growth of metastatic cancer in bone. Endocr. Relat. Cancer 6: 333-347.
35. GOLTZMAN, D., A.C. KARAPLIS, R. KREMEL, et al. 2000. Molecular basis of the spectrum of skeletal complications of neoplasia. Cancer 88: 2903-2908.
36. ROODMAN, G.D. 2003. Role of stromal-derived cytokines and growth factors in bone metastasis. Cancer 97: 733-738.
37. VOGELSTEIN, B. & K. KINZLER. 2004. Cancer genes and the pathways they control. Nat. Med. 10: 789-799.
38. PARSON, J.T., B. ZETTER & S. MOHLA. 2002. Shifting paradigms in tumor metastasis: challenges and opportunities. Cancer Biol. Ther. 1: 582-585.
39. LELEKAKIS, M., J.M. MOSELEY, T.J. MARTIN, et al. 1999. A novel orthotopic model of breast cancer metastasis to bone. Clin. Exp. Metastasis 17: 163-170.
40. SASAKI, A., B.F. BOYCE, B. STORY, et al. 1995. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone and nude mice. Cancer Res. 55: 3551-3557.
41. MBALAVIELE, G., C.R. DUNSTAN, A. SASAKI, et al. 1996. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res. 56: 4063-4070.
42. KANG, Y., P. SIEGEL, W. SHU, et al. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
43. NEMETH, J.A., J.F. HARB, U. BARROSO JR., et al. 1999. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res. 59: 1987-1993.
44. SHTIVELMAN, E. & R. NAMIKAWA. 1995. Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue. Proc. Natl. Acad. Sci. USA 92: 4661-4665.
45. YONOU, H., T. YOKOSE, T. KAMIJO, et al. 2001. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res. 61: 2177-2182.
46. DHANASEKARAN, S.M., T.R. BARRETTE, D. GHOSH, et al. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
47. EUER, N., M. SCHWIRZKE, V. EVTIMOVA, et al. 2002. Identification of genes associated with metastasis of mammary carcinoma in metastastic versus non-metastatic cell lines. Anticancer Res. 22: 733-740.
48. NELSON, P.S., N. CLEGG, H. ARNOLD, et al. 2002. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. USA 99: 11895.
49. BEER, D.G., S.L.R. KARDIA, C.C. HUANG, et al. 2002. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8: 816-824.
50. SHIPP, M.A., K.N. ROSS, P. TAMAYO, et al. 2002. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8: 68.
51. VAN'T VEER, L.J. & D. DE JONG. 2002. The microarray way to tailored cancer treatment. Nat. Med. 8: 13.
52. CALDAS, C. & S. APARICIO. 2002. The molecular outlook. Nature 415: 484-485.
53. VAN'T VEER, L.J., H. DAI, M.J. VAN DE VIJVER, et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
54. VAN'T VEER, L., P. SOONMYUNG & D. HAYES. 2005. Gene expression profiling of breast cancer: a new tumor marker. J. Clin. Oncol. 23: 1631-1635.
55. GLINSKY, G., O. BEREZOVSKA & A. GLINSKII. 2005. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115: 1503-1521.
56. CHANG, J.C., S.G. HILLSENBECK & S. FUQUA. 2005. Genomic approaches in the management and treatment of breast cancer. Br. J. Cancer 92: 618-624.
57. GRADISHAR, W. 2005. The future of breast cancer: the role of prognostic factors. Breast Cancer Res. Treat. 89: S17-S26.
58. DEXTER, D.L., H.M. KOWALSKI, B.A. BLAZAR, et al. 1978. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res. 38: 3174-3181.
59. MILLER, F.R., B.E. MILLER & G.H. HEPPNER. 1983. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis 3: 22-31.
60. JAEGER, E.B., R.S. SAMANT & C.W. RINKER-SCHAEFFER. 2001. Metastasis suppression in prostate cancer. Cancer Metastasis Rev. 20: 286.
61. WELCH, D.R. & C.W. RINKER-SCHAEFFER. 1999. What defines a useful marker of metastasis in human cancer? J. Natl. Cancer Inst. 91: 1351-1353.
62. MINN, A., Y. KANG, I. SERGANOVA, et al. 2005. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115: 44-55.
63. MINN, A., G. GUPTA, P. SIEGEL, et al. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
64. MANOLAGAS, S.C. 2006. Role of cytokines in bone resorption. Bone 17: 63S-67S.
65. VAN DE VIJVER, M.J. et al. 2002. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347: 1999-2009.
66. ELENBAAS, B., L. SPIRIO, F. KOERNER, et al. 2001. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15: 50-65.
67. HAHN, W.C., C.M. COUNTER, A.S. LUNDBERG, et al. 1999. Creation of human tumor cells with defined genetic elements. Nature 400: 464-468.
68. KUPERWASSER, C., S. DESSAIN, B. BIERBAUM, et al. 2005.Amouse model of human breast cancer metastasis to human bone. Cancer Res. 65: 6130-6138.
69. SATOH, N., T. KUDO, H. SAEKI, et al. 1995. A new and efficient method to generate human IGC monoclonal antibodies reactive to cancer cells using SCID-hu mice. Immunol. Lett. 47: 113-119.
70. ZANG, R.D., I.J. FIDLER & J.E. PRICE. 1991. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 11: 204-215.
71. KIM, U.J., J. PARK, H.J. WADA, et al. 2005. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26: 2775-2785.